Zibotentan, DAPAGLIFLOZIN, Zibotentan placebo, Dapagliflozin placebo
ZEAL-UNLOCK
Phase 2 small_molecule active
Quick answer
Zibotentan, DAPAGLIFLOZIN, Zibotentan placebo, Dapagliflozin placebo for Cirrhosis of the liver is a condition in which the liver is scarred and damaged is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Cirrhosis of the liver is a condition in which the liver is scarred and damaged
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active